BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Applied DNA Sciences, Inc. (APDN) to Host Conference Call Friday, February 15, 2013


2/13/2013 10:14:06 AM

STONY BROOK, NY--(Marketwire - February 12, 2013) - Applied DNA Sciences, Inc. (OTCBB: APDN), a provider of DNA-based security and anti-counterfeiting technology and product authentication solutions, will host a conference call on Friday, February 15, 2013 to discuss its earnings.

Applied DNA Sciences, Inc. management will host a thirty-minute conference call beginning at 9:00 a.m. eastern standard time on Friday, February 15, 2013 to discuss the company's performance and outline key ongoing and future business initiatives. A presentation by CEO and President James Hayward will be followed by a question-and-answer session.

All participants must pre-register using the link below. It is suggested that you log into the conference call approximately 10 minutes prior to the scheduled start time to ensure that all participants are on-line at the start of the call. While callers cannot be heard during the call, questions may be emailed beforehand to investor@adnas.com.

For those of you unable to participate, a transcript of the call will be posted by end of business on February 15, and available under the "Investors" tab of the company's web site.

To Participate:
Reserve your spot now at: https://www3.gotomeeting.com/register/176683054

To Send Questions Prior to the Call:
Please email questions prior to the call to investor@adnas.com.

Due to the large number of expected participants, not all questions may be answered on the call.

Company Background Materials:
You may be interested in the company's Investor Information section on the company's web site, including publications, recent press releases, blogs, and other materials.

About APDN
APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and BioMaterial Genotyping™, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2012 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.


INVESTOR CONTACT:
Debbie Bailey
631-444-8090

MEDIA CONTACT:
Mitchell Miller
646-543-3373

FCMN Contact:
Email Contact
Web site: http://www.adnas.com
Twitter: @APDN



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES